Rhythm Pharmaceuticals, Inc.
USD110.41
+0.37 (+0.33%)
CEO
David Meeker
IPO Date
2017-10-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$110.28
Prev. Close
$110.04
Day Low
$108.99
Day High
$111.27
52W Low
$62.84
52W High
$122.20
Market Cap
$7.57B
Volume
0.04M
| -13.1 |
| 31 Dec 2023 | FY | 88.0% | -238.5% | -108.8% | -55.5% | 0.01 | 5.58 | -14.4 |
| 31 Dec 2022 | FY | 91.0% | -766.2% | -68.5% | -47.4% | 0.01 | 8.90 | -8.4 |
| 31 Dec 2021 | FY | 81.0% | -2207.1% | -24.5% | -21.1% | 0.01 | 7.10 | -7.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -78.5% | -69.9% | 0.02 | 10.10 | -10.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -47.9% | -43.6% | 0.01 | 12.38 | -6.2 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -30.1% | -28.5% | 0.00 | 19.05 | -11.3 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -23.3% | -22.2% | 0.00 | 22.42 | -23.0 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -354.6% | -209.7% | 0.00 | 2.36 | -19.4 |
| -37.7 |
| 30 Sept 2025 | Q3 | 89.3% | -103.1% | -35.5% | -10.4% | 1.01 | 4.75 | -30.7 |
| 30 Jun 2025 | Q2 | 88.6% | -96.1% | 391.6% | -12.5% | -21.79 | 2.79 | -21.6 |
| 31 Mar 2025 | Q1 | 88.8% | -151.4% | -30.4% | -12.8% | 0.02 | 3.30 | -16.9 |
| 31 Dec 2024 | Q4 | 90.9% | -103.5% | -26.3% | -11.0% | 0.02 | 3.24 | -19.9 |
| 30 Sept 2024 | Q3 | 88.5% | -131.2% | -28.6% | -12.0% | 0.03 | 3.49 | -18.4 |
| 30 Jun 2024 | Q2 | 89.9% | -110.9% | -18.0% | -8.4% | 0.02 | 6.53 | -20.2 |
| 31 Mar 2024 | Q1 | 89.2% | -544.4% | -229.6% | -54.7% | 0.02 | 4.35 | -4.5 |
| 31 Dec 2023 | Q4 | 86.7% | -171.8% | -24.5% | -12.5% | 0.01 | 5.58 | -16.3 |